In accordance with Article 14 of the Belgian Transparency law of May 2, 2007, Azelis Group NV (Brussels:AZE) announces that it has received a transparency notification from First ...
CVR Partners maintains operational strength across fertilizer markets Expanding product lines support agricultural ecosystems Structured manufacturing processes reinforce long-term relevance CVR ...
2 Gringos Chupacabra, a Texas-based seasonings manufacturer, filed a trade secrets lawsuit against former employee Brian Henk on Oct. 15 in Texas Western District Court. The complaint, brought by ...
Natural naphthoquinones such as lapachol (Lp) have demonstrated promising biological activities. However, these quinones present low systemic biodisponibility due to its poor aqueous solubility. To ...
The updated mRNA vaccines target the LP.8.1 variant of SARS-CoV-2. The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and ...
The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and mNexspike ®. The updated mRNA vaccines target the LP.8.1 variant of ...
The updated vaccines are expected to be available in the coming days. The US Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines, Spikevax and ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback